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Abstract
Background
Levels of the -3 long-chain polyunsaturated fatty acids 3 LC-PUFAs), including 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been 
associated with alcohol sensitivity in vertebrate and invertebrate model systems, 
but prior studies have not examined this association in human samples despite 
evidence of associations between 3 LC-PUFA levels and alcohol-related 
phenotypes. Both alcohol sensitivity and 3 LC-PUFA levels are impacted by 
genetic factors, and these influences may contribute to observed associations 
between phenotypes. Given the potential for using EPA and DHA supplementation in
adjuvant care for alcohol misuse and other outcomes, it is important to clarify how 
3 LC-PUFA levels relate to alcohol sensitivity.
Methods
Analyses were conducted using data from the Avon Longitudinal Study of Parents 
and Children (ALSPAC). Plasma 3 LC-PUFA levels were measured at ages 15.5 and 
17.5. Participants reported on their initial alcohol sensitivity using the early drinking
Self-Rating of Effects of Alcohol (SRE-5) scale, for which more drinks needed for 
effects indicates lower levels of response per drink, at ages 15.5, 16.5, and 17.5. 
Polygenic liability for alcohol consumption, alcohol problems, EPA levels, and DHA 
levels were derived using summary statistics from large, publicly available datasets.
Linear regressions were used to examine the cross-sectional and longitudinal 
associations between 3 LC-PUFA levels and SRE scores.
Results
Age 15.5 3 LC-PUFA levels were negatively associated with contemporaneous SRE
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polygenic liability and SRE scores was observed, between alcohol problems-based 
PRS and age 16.5 SRE scores. Tests of moderation by genetic liability were not 
warranted.
Conclusions
Plasma 3 LC-PUFA levels may be related to initial sensitivity to alcohol during 
adolescence. These data indicate that diet-related factors have the potential to 
impact humans’ earliest responses to alcohol exposure.
Key words: ALSPAC, 3 long-chain polyunsaturated fatty acids, alcohol sensitivity,
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Introduction
Alcohol problems are common in the US and other Western societies: A 2015 
study of a population-based adult cohort reported a lifetime prevalence of 29.1% for
DSM-5 alcohol use disorder (AUD) (Grant et al., 2015) and the World Health 
Organization estimated that 16.0% of drinkers aged 15 and older engage in heavy 
episodic drinking (World Health Organization, 2014). Due to the impact of excessive
alcohol use on health and productivity, the economic consequences are substantial, 
estimated at $249 billion in 2010 in the US alone (Sacks et al., 2015). Clarifying the 
biological and environmental factors that contribute to the risk of developing 
alcohol problems is, therefore, a public health priority. 
Long-chain 3 polyunsaturated fatty acid (3 LC-PUFA; also known as highly
unsaturated fatty acids [HUFA]) levels are a primarily environmental factor that has 
been associated with acute ethanol response behaviors in both invertebrate and 
vertebrate models. In C. elegans, genetic contributors to a low level of response 
(low LR) to alcohol have been identified (Davies et al., 2003), and the development 
of acute functional tolerance (AFT) to ethanol requires the long chain 3 
eicosapentaenoic acid (EPA) (Raabe et al., 2014). Supplementation of additional EPA
can enhance AFT, indicating that EPA levels can influence the acute response to 
ethanol in C. elegans (Raabe et al., 2014). In mice, dietary levels of long chain 3s 
interact with the genetic background to alter several acute ethanol responses 
including low dose locomotor activation and high dose sedation. Intriguingly, in 
C57BL/6J mice but not DBA/2J mice, dietary EPA and DHA increased voluntary 
ethanol consumption (Wolstenholme et al., 2018)
 Acute ethanol response behaviors, including AFT, in model organisms are a 
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sensitivity to alcohol is a partially heritable phenotype (Edwards et al., 2018, Heath 
et al., 1999, Schuckit, 2018) which has been associated with later alcohol 
consumption and problems (Schuckit, 1994, Schuckit et al., 2007). Lower initial 
sensitivity to alcohol is a risk factor for higher alcohol consumption and subsequent 
problems. Improved understanding of factors that impact one’s alcohol sensitivity 
may therefore be useful in understanding trajectories from early to problematic 
alcohol use and has been used as a focus for prevention programs (Schuckit et al., 
2016).
The effect of 3 LC-PUFA levels on the physiological response to ethanol may
be of particular relevance to human alcohol use: Human EPA and DHA levels are 
primarily determined by diet, making them an easily modifiable target for alcohol 
studies. Indeed,EPA and DHA supplementation, usually from fish oil, is common, 
and can have significant impacts on the levels of 3 LC-PUFAs in plasma (Superko 
et al., 2013). However, in humans, little is known about how the levels of 3 LC-
PUFAs may be related to alcohol sensitivity.
 Here, we sought evidence for a relationship between measured plasma 3 
LC-PUFA levels and alcohol sensitivity in the Avon Longitudinal Study of Parents and
Children (ALSPAC). We capitalized on the availability of repeated measures of 
plasma 3 LC-PUFA levels and self-reported initial sensitivity to alcohol (SRE-5) 
across adolescence to test whether these measures were related, and if so, if the 
relationship was contemporaneous and/or whether 3 LC-PUFA levels are 
associated with later alcohol sensitivity. Prior evidence indicates that both initial 
alcohol sensitivity and 3 LC-PUFA levels are genetically influenced (Edwards et al.,
2018, Lemaitre et al., 2011, Steer et al., 2012). The aforementioned differences in 
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a function of genetic background in mice (Wolstenholme et al., 2018) raises the 
question of whether genetic factors may have a similar impact in humans. We 
therefore further assessed if polygenic liability for alcohol-related phenotypes 
and/or 3 LC-PUFA blood levels contributes to any association between 3 levels 
and alcohol sensitivity. Incorporation of aggregate genetic factors may clarify 
models of biological mechanism(s) contributing to the relationship between 3 LC-
PUFA levels and alcohol outcomes. Furthermore, should genetic factors prove 
influential in this association, they could potentially inform the suitability of using 
EPA and DHA supplements in treatment settings. 
Materials and Methods
Sample 
There were 14,541 initial pregnancies for which the mothers enrolled in the 
Avon Longitudinal Study of Parents and Children (ALSPAC) study and had either 
returned at least 1 questionnaire or attended a “Children in Focus” clinic by July 19, 
1999. Of these initial pregnancies, there was a total of 14,062 live births and 13,988
children who were alive at 1 year of age. Subsequent phases of enrollment 
increased the sample size over time (Fraser et al., 2013, Boyd et al., 2013). The 
phases of enrollment are described in more detail elsewhere (Fraser et al., 2013, 
Boyd et al., 2013). Only offspring genotypes were used in the current analyses. 
Participants are encouraged to contribute to assessments whenever possible even if
not at every wave, and are permitted to skip questions within an assessment; 
accordingly, there is often variation across and within waves with respect to data 
availability for a given participant. The study website contains details of all the data 
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alspac/researchers/our-data/). Beginning with the age 22 assessment, online 
questionnaires were administered using REDCap (Harris et al., 2009). Ethical 
approval for the study was obtained from the ALSPAC Ethics and Law Committee 
and the Local Research Ethics Committees. Informed consent for the use of data 
collected via questionnaires and clinics was obtained from participants following the
recommendations of the ALSPAC Ethics and Law Committee at the time.
Alcohol sensitivity 
Sensitivity to alcohol was assessed using the Self-Rating of the Effects of 
Alcohol (SRE) scale (Schuckit et al., 1997). The SRE consists of 4 items; for the 
current study, each item referred to the first five or so times, the SRE-5, a 
participant used alcohol (referred to hereafter as SRE). Participants were asked to 
report the number of standard drinks they usually needed to consume to 
experience any effect of the alcohol, slur their speech, feel unsteady on their feet, 
or intentionally fall asleep. Consistent with prior reports (Edwards et al., 2018) 
responses were winsorized to limit extreme values and reduce the effect of possibly
spurious outliers. SRE scores were calculated by summing the drinks needed for 
effects across items and dividing by the number of the up to four effects 
experienced, as recommended by Schuckit and colleagues (Schuckit et al., 1997). 
Thus, higher SRE scores correspond to lower initial alcohol sensitivity. The current 
study included SRE reports from approximate ages 15.5 (n=3285), 16.5 (n=1398), 
and 17.5 (n=942), which correspond to a time frame during which initiation of 
alcohol use is common and thus increases the likelihood that participants are 
reporting on their first experiences with alcohol.  
Because we were interested in relationships between initial alcohol sensitivity
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sensitivity was used. That is, if a participant responded to the SRE questionnaire 
items at ages 15.5 and 16.5, only the age 15.5 response was included in 
regressions; this decision was made to increase the likelihood that scores more 
closely reflected the participant’s first exposure to five or so drinks, as we were 
concerned that recall bias and/or more recent alcohol use experiences may impact 
responses during later assessments. Due to attrition and the fact that most 
participants had initiated alcohol use prior to age 16.5, a consequence of this 
decision was a smaller sample size in analyses for which the outcome was SRE 
score at age 16.5 or 17.5.
3 LC-PUFA blood levels
ALSPAC participants periodically participate in clinics wherein physiological 
measures are taken in addition to typical questionnaire assessments. Fasting 
(minimum of 6 hours) plasma lipids were assessed at participant ages 15.5 
(n=3361) and 17.5 (n=3166) (an assessment at age 7.5 was excluded as it was 
temporally distant from SRE reports). Lipids were measured using a high-throughput
nuclear magnetic resonance metabolomics platform (Soininen et al., 2015, Soininen
et al., 2009). We restricted our analyses to total 3 LC-PUFAs; data are in mmol/L.
Polygenic liability
To assess whether genetic factors relevant to alcohol outcomes and/or 3 
LC-PUFA are related to any observed association between 3 LC-PUFA levels and 
initial alcohol sensitivity, we constructed polygenic risk scores for individuals within 
ALSPAC. PRS are derived by multiplying beta estimates (or odds ratios) for an effect 
allele at a particular locus – estimated in an independent sample – by the number of
effect alleles an individual carries at that locus. This is repeated at the genome-wide
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reflects their aggregate genetic liability for a phenotype of interest (in this case, 
AUDIT scores and plasma EPA and DHA levels). Additional information on PRS is 
available in Choi et al. (2018) and Sugrue and Desikan (2019).
To derive PRS for the current study, we obtained publicly available summary 
statistics from the most well-powered and phenotypically appropriate GWAS 
identified through a literature search. Although a meta-analysis of two GWAS of SRE
scores is available (Edwards et al., 2018) that study included the ALSPAC sample, 
rendering it unsuitable as a discovery dataset. We therefore used summary 
statistics from a GWAS of AUDIT (Babor et al., 2001) scores in the UK Biobank 
sample (Bycroft et al., 2018, Sanchez-Roige et al., 2019) disaggregated into the 
AUDIT-C and AUDIT-P to enable detection of potential differences in the association 
between genetic liability to each construct with 3 LC-PUFA levels. AUDIT-C 
consists of the first three AUDIT items and captures past-year alcohol consumption; 
AUDIT-P consists of the remaining 7 AUDIT items and captures past-year 
problematic use. Because the aim was to account for polygenic liability to alcohol 
consumption/problems rather than to dissect the impact of loci implicated at 
various levels of significance, only the inclusive p<0.50 threshold PRS was derived 
for inclusion as a predictor. Note that, while the Sanchez-Roige report includes both 
UK Biobank and 23andMe participants, only summary statistics for the former were 
used in the current analyses.
To account for genetic factors associated with 3 LC-PUFA levels, we 
downloaded summary statistics from meta-analyses of GWAS on plasma EPA and 
DHA levels, made available by the CHARGE Consortium 
(http://www.chargeconsortium.com/main/results) and reported by Lemaitre et al. 
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making it suitable as a discovery sample for ALSPAC. We chose to analyze the long-
chain polyunsaturated fatty acids EPA and DHA because these long chain 3 fatty 
acids had been directly tested in animal models and had been shown to affect 
ethanol sensitivity (Wolstenholme et al., 2018) In addition, EPA and DHA are the 
main constituents of fish oil, a common dietary supplement.
Genotypes for ALSPAC participants are available for a fee to researchers will 
an approved project (see http://www.bristol.ac.uk/alspac/researchers/ for details). 
Genotyping and initial quality control of data were performed by ALSPAC analysts, 
unrelated to the current project. Genotyping in ALSPAC was performed on the 
Illumina HumanHap550 quad genome-wide SNP genotyping platform by 23andMe 
subcontracting the Wellcome Trust Sanger Institute, Cambridge, UK, and the 
Laboratory Corporation of America, Burlington, NC, USA. Individuals were excluded 
from analyses on the basis of excessive or minimal heterozygosity, gender 
mismatch, individual missingness (0.3%), cryptic relatedness as measured by 
identity by descent (genome-wide IBD 0.10%) and sample duplication. Individuals 
were assessed for population stratification using multi-dimensional scaling 
modelling seeded with HapMap Phase II release 22 reference populations. 
Individuals of non-European ancestry were removed from further analysis. ShapeIt 
v2 was used to impute to 1000 Genomes Phase 1, Version 3, Release December 
2013. We excluded markers with MAF<0.01, deviation from HWE (p < 5 x 10-6), 
genotyping rate <0.95, or INFO <0.80. Polygenic risk scores were derived using the 
--score and --dosage options in Plink 1.9 (www.cog-genomics.org/plink/1.9/) (Chang 
et al., 2015) for markers with p<0.5 in the discovery sample. This corresponding to 
the following numbers of SNPs contributing to the four PRS after pruning: AUDIT-C, 
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Statistical analyses
Analyses were conducted in R version 3.4.3 using the glm function, 
potentially using three stages of multivariable regressions. In the first stage, SRE 
scores were regressed onto 3 LC-PUFA levels, including biological sex (determined
at birth) as a covariate. In the second stage, we added the main effects of ancestry-
informative principal components as well as polygenic scores for alcohol 
consumption, alcohol problems, DHA, and EPA. In the third stage, we added 
interaction terms between 3 LC-PUFA levels and any PRS variable for which a 
main effect (p<0.05) was observed for both the variables in the second stage, in 
order to test whether polygenic liability for the trait(s) in question moderated the 
3 LC-PUFA→SRE association.
Although our primary research question focused on contemporaneous 3 LC-
PUFA and SRE, we also considered the possibility that 3 LC-PUFA level would 
impact later SRE scores. We therefore ran regression models in which the age 15.5 
3 LC-PUFA measure was the predictor of interest for SRE at age 16.5 or 17.5. SRE 




Table 1 provides descriptive statistics for 3 LC-PUFA levels and SRE scores 
across waves. 3 LC-PUFA levels at ages 15.5 and 17.5 were correlated at r = 0.49 
(p < 0.0001). Correlations within SRE scores were not calculated since only the first 
report was used for each individual. Both alcohol-related PRS were weakly positively
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higher genetic liability to alcohol consumption/problems was correlated with 
needing more standard units of alcohol to perceive its effects (i.e., lower alcohol 
sensitivity). DHA/EPA PRS were weakly positively correlated with 3 LC-PUFA levels 
(r = 0.02-0.05, p = 0.01-0.22). Correlations across 3 LC-PUFA levels and SRE 
scores ranged from r = -0.18 to r = -0.05 (p < 0.01-0.38; Figure). 
Model 1 regression results
Table 2 (top panel) provides results from Model 1, in which SRE scores were 
regressed onto 3 LC-PUFA levels and sex. Higher 3 LC-PUFA levels at age 15.5 
were nominally associated (p<0.05) with lower SRE scores (i.e., higher initial alcohol
sensitivity) at ages 15.5 and 17.5, but not at age 16.5. Age 17.5 3 LC-PUFA levels 
were not associated with concurrent SRE scores.
Model 2 regression results
We next added PRS for alcohol consumption, alcohol problems, DHA levels, 
and EPA levels as potential predictors of initial alcohol sensitivity. Results are 
presented in Table 2 (bottom panel). The associations between higher age 15.5 3
LC-PUFA levels and lower SRE scores (i.e., higher alcohol sensitivity) at ages 15.5 
and 17.5 persisted in these adjusted models. We also observed a negative 
association between AUDIT-P PRS and age 16.5 SRE scores. No other PRS was 
associated with SRE score at any age (all p≥0.05). Because the only main effect of 
PRS was observed in a model in which no significant main effect of 3 LC-PUFA was
observed, we did not test for an interaction with the PRS score. 
Discussion
Prior research in model systems has demonstrated that 3 LC-PUFA levels 
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3 LC-PUFA levels and sensitivity to alcohol in humans have not been reported, to 
our knowledge. Our analyses tested for an association between plasma 3 LC-PUFA
levels and initial sensitivity to alcohol in a population-based sample of adolescents. 
We also assessed whether genetic factors underlying to alcohol outcomes 
(consumption or problems) or EPA/DHA levels further contributed to initial alcohol 
sensitivity. We found that higher 3 LC-PUFA levels were associated with higher 
alcohol sensitivity in some, but not all, analyses. Polygenic scores exhibited little to 
no effect on the outcome, and moderation tests were not warranted. In conjunction 
with results from model systems, these findings extend our understanding of the 
relationship between 3 LC-PUFA levels and alcohol outcomes to include an 
individual’s earliest experiences with the drug.
3 LC-PUFA levels assessed at age 15.5 were associated with SRE scores 
both concurrently and two years later, but not with SRE scores in the intervening 
year. While the effect size at age 17.5 is nearly twice that at age 15.5, the standard 
error is much higher in the former and the corresponding significance value much 
weaker, and we observed no association between 3 LC-PUFA levels and age 16.5 
initial sensitivity. We conducted four multivariable analyses, for which a 
corresponding conservative correction would require p<0.0125 to achieve statistical
significance. This correction would further call into question the association between
age 15.5 3 LC-PUFA level and age 17.5 SRE; the within-age 15.5 association 
survives the correction. Our data, therefore, can most cautiously be interpreted as 
supporting a relationship between contemporaneous 3 LC-PUFA levels and initial 
alcohol sensitivity in early/mid-adolescence. 
We observed a main effect of aggregate genetic liability toward alcohol 
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age 16.5 SRE scores but in no other case. This association was not in the expected 
direction: Here, higher genetic liability to alcohol problems was associated with 
lower SRE scores (i.e., higher sensitivity). There were no main effects of polygenic 
liability for alcohol consumption, EPA levels, or DHA levels. Furthermore, in the 
absence of jointly observed main effects for both polygenic liability and 3 LC-PUFA
levels, moderation tests were not warranted. Thus, although both the outcome and 
predictor of interest are genetically influenced (Edwards et al., 2018, Lemaitre et 
al., 2011), it is unlikely that the degree of their phenotypic association in the 
ALSPAC sample is moderated by genetic factors. This observation is potentially 
pertinent to efforts to determine whether EPA and DHA supplementation could be 
used to modify the response to alcohol because, in the context of initial alcohol 
sensitivity in adolescence, response to 3 LC-PUFA supplementation is unlikely to 
depend heavily on one’s underlying genetic vulnerability to alcohol problems. 
It is important to note that the current approach does not determine whether 
the observed associations are causal in nature. In addition, because SRE scores are 
based on self-report, they may be imprecise and/or subject to recall bias. While 
ALSPAC participants are instructed to respond to the items used for the current 
study by recalling their first exposures to alcohol, these reports may be influenced 
by more recent drinking experiences. We therefore restricted our analyses to 
include only an individual’s first report on the SRE items (though participants are 
administered the “first 5 or so” SRE items repeatedly across waves) in an effort to 
capture the report that was closest in time to the initial alcohol experiences. 
We used a large, publicly available dataset of GWAS summary statistics for 
3 LC-PUFA (from the CHARGE Consortium). While a meta-analysis of initial alcohol 
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summary statistics from that study because genetic influences were driven by the 
ALSPAC sample, and therefore were not independent. We therefore elected to use 
summary statistics from the UK Biobank, as this is a statistically well-powered, 
population-based sample of the same ancestry as ALSPAC, and prior research 
indicates that PRS are more useful when used across similarly ascertained samples
(Savage et al., 2018) We used summary statistics based on adult phenotypes, and 
given the dynamic nature of diet and alcohol use across the life course, discovery 
samples closer in age to the ALSPAC sample will be valuable to analyze in the 
future.
This work adds to the growing appreciation of the effects of dietary 3 LC-
PUFA levels on neurobiological outcomes, including substance use and 
psychopathology. Here we found that basal levels of 3 LC-PUFA were associated 
with alcohol response in adolescence, though effect sizes were small and may not 
be clinically significant. Previously, a small study of treatment-seeking substance 
abusers found that low 3 LC-PUFA levels were associated with an increased risk of
relapse or study drop-out (Buydens-Branchey et al., 2009). Plasma 3 LC-PUFA 
levels were positively correlated with alcohol consumption in non-alcoholic people in
IMMIDIET study (di Giuseppe et al., 2009). Together, these observations underscore 
the potential clinical implications of 3 LC-PUFA levels on alcohol-related outcomes.
Our study is particularly significant because we examined a young population
and looked at initial responses to ethanol. In alcoholics, heavy drinking is associated
with dysregulation of 3 LC-PUFA levels, probably due in part to liver damage
(Vatsalya et al., 2016). It may therefore be difficult to distinguish between an effect 
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behavior on 3 levels. Our study of adolescents is less subject to that confound 
than studies of adults with long-term histories of heavy drinking.
The mechanisms whereby 3 LC-PUFAs may influence low responses to 
alcohol are beyond the scope of the current study but merit consideration. Both 3 
LC-PUFAs and alcohol engage neurotransmitter systems: Deficits in 3 LC-PUFAs 
adversely affect neuroinflammatory mechanisms (Laye et al., 2018) which in turn 
impact stress hypothalamic–pituitary–adrenal (HPA) axis sensitivity and other 
neurotransmitter systems (Levant, 2013). Effects of 3 LC-PUFA deficiencies on 
dopaminergic neurons can be pronounced, especially in the ventral striatum (Healy-
Stoffel and Levant, 2018). The dopaminergic system is of central relevance in 
alcohol responses (Schuckit, 2018); alcohol also has prominent simultaneous effects
on gamma-aminobutyric acid (GABA), glutamate, opioid, serotonin, and 
acetylcholine systems, and on the HPA axis, each of which could contribute to 
alcohol sensitivity (Schuckit, 2018). Future studies could potentially investigate 
whether high versus low 3 LC-PUFA levels may contribute to differences in alcohol
sensitivity via perturbation of specific neurotransmitter systems. 
In summary, we report an association between plasma 3 LC-PUFA levels 
and initial alcohol sensitivity in a population-based cohort of adolescents, such that 
higher 3 LC-PUFA levels correspond to higher alcohol sensitivity. These findings, 
which primarily support a contemporaneous association in mid-adolescence, 
warrant follow-up in an independent sample. While our observational study cannot 
address causality, the results raise the possibility that dietary 3 LC-PUFA levels 
could reduce low initial responses to alcohol, which has been previously associated 
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findings add to the growing body of literature suggesting important associations 
between low levels of 3 LC-PUFAs and increased risks for psychopathology.
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Figure caption
Correlations between unstandardized 3 long chain polyunsaturated fatty acid 
levels (in mmol/L; x-axis) and scores on the Self-Rating of the Effects of Alcohol 
(SRE; y-axis). Pearson correlations and corresponding p-values are presented, along
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Table 1. Descriptive statistics for 3 LC-PUFA levels and Self-Rating of the Effects 
of Alcohol (SRE) scores.
3 LC-PUFA  SRE Score1
 N Mean (SD) 
mmol/L
 N Mean (SD)
Age 15.5      
Total 3361 0.28 (0.07)  3285 5.40 (2.95)
Girls 1749 0.30 (0.07)  1869 5.07 (2.83)
Boys 1612 0.26 (0.07)  1416 5.82 (3.05)
      
Age 16.5      
Total n/a n/a  1398 4.58 (2.43)
Girls n/a n/a  877 4.35 (2.32)
Boys n/a n/a  521 4.98 (2.56)
      
Age 17.5      
Total 3166 0.30 (0.08)  942 5.14 (2.62)
Girls 1647 0.31 (0.08)  446 4.65 (2.26)
Boys 1519 0.28 (0.07)  496 5.58 (2.84)
1Figures are restricted to participants’ first SRE report, and represent UK standard drinks, 
one of which contains 8 grams of ethanol (a standard US drink has 14 grams of ethanol). The
participants whose first SRE report is at age 15.5 do not overlap with those whose first SRE 
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Table 2. Results from linear models where scores on the Self-Rating of the Effects of Alcohol (SRE) scale are 
regressed onto concurrent or prior 3 LC-PUFA levels and other potential predictors/covariates. In the interest of 
space, results for 10 ancestry-informative principal component covariates are not shown. Continuous variables were 
standardized prior to analysis, and beta coefficients represent the change in SRE associated with a unit change in 
3 LC-PUFA.
Age 15.5 3 LC-
PUFA and age 15.5
SRE
Age 15.5 3 LC-PUFA
and age 16.5 SRE
Age 15.5 3 LC-PUFA
and age 17.5 SRE
Age 17.5 3 LC-PUFA
and age 17.5 SRE







































AUDIT-C PRS 0.03 (0.03) 0.30 0.08 (0.07) 0.25 0.02 (0.06) 0.70 0.11 (0.05) 0.05




0.02 0.11 (0.06) 0.09 0.04 (0.05) 0.41
DHA PRS -0.01 
(0.03)
0.66 0.06 (0.08) 0.42 0.01 (0.06) 0.83 0.02 (0.05) 0.64




0.48 0.08 (0.06) 0.22 0.04 (0.05) 0.45
1Boys are the reference group
2mmol/L
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